HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection.

AbstractBACKGROUND:
Direct-acting antiviral (DAA) agents can successfully treat chronic hepatitis C virus (HCV) infection. However, the ex vivo HCV-specific T-cell function following viral clearance remains unknown.
METHODS:
We investigated functional alterations and phenotypic changes in ex vivo HCV-specific CD8+ T cells with a longitudinal analysis of 41 patients with chronic HCV infection who were undergoing DAA treatment.
RESULTS:
A patient subset exhibited a significantly increased T-cell response (mainly CD8+ T cells) at week 4 of treatment. However, this increased T-cell response diminished in later weeks. Relative to pretreatment levels, the ex vivo HCV-specific CD8+ T-cell frequency decreased at 12 weeks after the end of treatment, along with a decreased antigen-experienced CD8+ T-cell population. DAA treatment increased the proliferative capacity of HCV-specific CD8+ T cells, but this change was not correlated with ex vivo function. Patients experiencing viral breakthrough or relapse exhibited defective restoration of T-cell function.
CONCLUSION:
Our present results indicated that DAA-mediated viral clearance only transiently restored ex vivo T-cell function, suggesting a need to enhance T-cell function in DAA-treated patients.
AuthorsJi Won Han, Pil Soo Sung, Kyung Hwan Kim, Seon-Hui Hong, Eui-Cheol Shin, Myeong Jun Song, Su-Hyung Park
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 220 Issue 8 Pg. 1290-1301 (09 13 2019) ISSN: 1537-6613 [Electronic] United States
PMID31152667 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Chemical References
  • Antiviral Agents
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiviral Agents (pharmacology, therapeutic use)
  • CD8-Positive T-Lymphocytes (drug effects, immunology)
  • Cell Proliferation (drug effects)
  • Female
  • Hepacivirus (drug effects, immunology, isolation & purification)
  • Hepatitis C, Chronic (drug therapy, immunology, virology)
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Recurrence
  • Sustained Virologic Response
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: